期刊文献+

5%葡萄糖注射液对盐酸胺碘酮注射液所致静脉炎的效果评价 被引量:3

The Effect of 5% Dextrose Infusion for Phlebitis Caused by Amiodarone
原文传递
导出
摘要 目的探讨5%葡萄糖注射液对胺碘酮所致静脉炎的效果。方法将2011年6月-2012年3月收治的136例患者随机分为对照组63例和干预组73例。对照组遵医嘱以5%葡萄糖注射液500 mL加胺碘酮注射液600 mg以15滴/min静脉输注,1次/d,连续使用3 d;干预组在对照组输液治疗的基础上同时以5%葡萄糖注射液冲管,比较两组患者静脉炎并发症的发生率。结果对照组发生静脉炎22例(34.9%),干预组发生静脉炎11例(15.0%),两组比较差异有统计学意义(χ2=7.252,P=0.007)。结论输液治疗同时以5%葡萄糖注射液冲管可明显降低胺碘酮所致静脉炎的发生。 Objective To investigate the effect of 5% dextrose intravenous infusion for phlebitis caused by amiodarone. Methods A total of 136 patients treated in our hospital between June 2011 and March 2012 were randomly assigned into control group with 63 patients and intervention group with 73 patients. The control group was administrated 600 mg amiodarone with 15 drops/minute intravenous injection once daily, for 3 days, while for the intervention group patients, we added 5% dextrose solution infusion in the same channel at the same time. Results Phlebitis occurred in 22 patients (34.9%) in the control group, while the intervention group had only 11 (15.0%) (χ2=7.252,P=0.007). Conclusion Infusion of 5% dextrose solution can significantly reduce the occurrence of phlebitis caused by amiodarone.
出处 《华西医学》 CAS 2014年第9期1723-1725,共3页 West China Medical Journal
关键词 5%葡萄糖注射液 胺碘酮 静脉炎 效果评价 5% Dextrose infusion Amiodarone Phlebitis Effect evaluation
  • 相关文献

参考文献15

二级参考文献58

共引文献189

同被引文献37

  • 1胡雁.正确认识循证护理 推动护理实践发展[J].中华护理杂志,2005,40(9):714-717. 被引量:283
  • 2Camm A J, Lip G Y, De Caterina R, et al. 2012 focused up- date of the ESC Guidelines for the management of atrial fi brillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association[J]. Eur Heart J,2012,33(21) :2719-2747.
  • 3Norton L, Ottoboni L K, Varady A, et al. Phlebitis in amiodarone administration: incidence, contributing fac- tors, and clinical implications[J]. Am J Crit Care, 2013, 22(6) :498-505.
  • 4Robin P N, Sandra L D, Stephanie S P, et al. Johns Hopkins nursing: evidence based practice model and guidelines[M]. Indiana: Sigma Theta Tau International, 2007:204-207.
  • 5Boyce B A, Yee B H. Incidence and severity of phlebitisin patients receiving peripherally infused amiodarone[J]. Crit Care Nurse,2012,32(4) :27-34.
  • 6Ward G H, Yalkowsky S H. Studies in phlebitis. VI: Dilution-induced precipitation of amiodarone HCL[J]. J Parenter Sci Technol, 1993,47 (4) : 161-165.
  • 7Ward G H, Nolan P E Jr, Chawla M, et al. Studies in phlebitis: detection and quantitation using a thermo- graphic camera[J]. Pharm Res,1991,8(1) :76- 79.
  • 8Uslusoy t, Mete S. Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descrip tive study[J]. J Am Acad Nurse Pract,2008,20(4) :172- 180.
  • 9Curran E T, Coia J E, Gilmour H, et al. Multi-centre re- search surveillance project to reduce infections/phlebitis associated with peripheral vascular catheters[J]. J Hosp Infect, 2000,46 (3) : 194-202.
  • 10Infusion Nurses Society. Infusion Nursing Standards of Practice[J]. J Infus Nurs, 2006,29 (1 Suppl) : S1 -S92.

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部